Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.

The risk of developing neoplasia leading to colorectal cancer is significantly increased in ulcerative colitis (UC) and most likely in Crohn's disease. Several endoscopic surveillance strategies have been implemented to identify these lesions. The main issue is that colitis-associated neoplasms often occurs in flat mucosa, often being detected on taking random biopsies rather than by identification of these lesions via endoscopic imaging. The standard diagnostic procedure in long lasting UC is to take four biopsies every 10 cm. Image enhancement methods, such as chromoendoscopy and virtual histology using endomicroscopy, have greatly improved neoplasia detection rates and may contribute to reduced random biopsies by taking targeted "smart" biopsies. Chromoendoscopy may effectively be performed by experienced endoscopists for routine screening of UC patients. By contrast, endomicroscopy is often only available in selected specialized endoscopic centers. Importantly, advanced endoscopic imaging has the potential to increase the detection rate of neoplasia whereas the interplay between endoscopic experience and interpretation of histological biopsy evaluation allows the physician to make a proper diagnosis and to find the appropriate therapeutic approach. Colitis-associated intraepithelial neoplasms may occur in flat mucosa of endoscopically normal appearance or may arise as dysplasia-associated lesion or mass (DALM), which may be indistinguishable from sporadic adenomas in healthy or non-colitis mucosa [adenoma-like mass (ALM)]. The aim of this review was to summarize endoscopic and histological characteristics of DALM and ALM in the context of therapeutic procedures.

[1]  I. Brock,et al.  Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms. , 2003, Human pathology.

[2]  C. Bernstein,et al.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.

[3]  Bernhard Nafe,et al.  Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. , 2003, Gastroenterology.

[4]  Helmut Neumann,et al.  New endoscopic approaches in IBD. , 2011, World journal of gastroenterology.

[5]  M. Vieth,et al.  Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment , 2005, Gut.

[6]  H. Mitomi,et al.  Decreased expression of CD44, alpha‐catenin, and deleted colon carcinoma and altered expression of beta‐catenin in ulcerative colitis‐associated dysplasia and carcinoma, as compared with sporadic colon neoplasms , 2000 .

[7]  C. Loddenkemper Diagnostic Standards in the Pathology of Inflammatory Bowel Disease , 2009, Digestive Diseases.

[8]  S. Cross,et al.  Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. , 2005, Endoscopy.

[9]  Helmut Neumann,et al.  Confocal laser endomicroscopy: technical advances and clinical applications. , 2010, Gastroenterology.

[10]  C. Florent,et al.  Dysplasia and cancer in ulcerative colitis. , 1989, Hepato-gastroenterology.

[11]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[12]  N. Harpaz,et al.  Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. , 1995, Cancer research.

[13]  M. Esaki,et al.  Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study. , 2007, Gastrointestinal endoscopy.

[14]  R. Odze Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. , 1999 .

[15]  E. Dekker,et al.  Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions , 2008, Gut.

[16]  R. Kiesslich,et al.  Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. , 2007, Gastroenterology.

[17]  M. Neurath,et al.  Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications , 2006, Gut.

[18]  T. Rognum,et al.  Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. , 1998, Molecular pathology : MP.

[19]  M F Neurath,et al.  Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight , 2004, Gut.

[20]  M. Vieth,et al.  Die schwierige Differenzialdiagnose der sporadischen Adenome und kolitisassoziierten intraepithelialen Neoplasien bei Colitis ulcerosa , 2003, Der Pathologe.

[21]  P. Malfertheiner,et al.  Double-balloon enteroscopy-assisted virtual chromoendoscopy for small-bowel disorders – a case series , 2009, Endoscopy.

[22]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[23]  Shinji Tanaka,et al.  Pragmatic classification of superficial neoplastic colorectal lesions. , 2009, Gastrointestinal endoscopy.

[24]  S. Cross,et al.  Confocal endomicroscopy in ulcerative colitis: differentiating dysplasia-associated lesional mass and adenoma-like mass. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  M. Vieth,et al.  The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. , 1999, Human pathology.

[26]  A. Forbes,et al.  Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis , 2004, Gut.

[27]  R. Odze,et al.  Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. , 1999, Gastroenterology.

[28]  N. Shepherd,et al.  Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. , 2009, Gastroenterology.

[29]  P. Malfertheiner,et al.  Advanced colon polypectomy. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  M. Stolte,et al.  Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis. , 1993, Zeitschrift fur Gastroenterologie.

[31]  D. Forman,et al.  Ten year follow up of ulcerative colitis patients with and without low grade dysplasia , 2003, Gut.

[32]  M. Neurath,et al.  Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. , 2008, Current drug targets.

[33]  R. Haggitt,et al.  Cancer surveillance in ulcerative colitis. , 1991, Gastroenterology.

[34]  A. Forbes,et al.  Most dysplasia in ulcerative colitis is visible at colonoscopy. , 2004, Gastrointestinal endoscopy.

[35]  R. Odze,et al.  Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  D. Ransohoff,et al.  Nonpolypoid neoplastic lesions of the colorectal mucosa. , 2008, Gastrointestinal endoscopy.

[37]  D. Present,et al.  Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. , 2005, Inflammatory bowel diseases.

[38]  T. Fujimori,et al.  Colonoscopic diagnosis of dysplasia and early cancer in longstanding colitis. , 1995, Journal of gastroenterology.

[39]  M. Neurath,et al.  Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. , 2007, Inflammatory bowel diseases.

[40]  R. Odze,et al.  Genetic Alterations in Chronic Ulcerative Colitis-Associated Adenoma-Like DALMs Are Similar to Non-Colitic Sporadic Adenomas , 2000, The American journal of surgical pathology.

[41]  C. Williams,et al.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. , 1994, Gastroenterology.

[42]  S. Cross,et al.  Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. , 2004, Gastroenterology.

[43]  M. Stolte,et al.  Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas. , 1998, Human pathology.

[44]  R. Odze,et al.  Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. , 2009, Inflammatory bowel diseases.

[45]  F. Waldman,et al.  The APC/β‐catenin pathway in ulcerative colitis–related colorectal carcinomas , 2002, Cancer.